Department of Genetics, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Department of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
J Clin Endocrinol Metab. 2018 May 1;103(5):1889-1898. doi: 10.1210/jc.2017-02202.
Congenital hypothyroidism (CH) is the most common neonatal endocrine disorder, affecting one in 3000 to 4000 newborns. Since the introduction of a newborn screening program in 1988, more than 300 cases have been identified. The underlying genetic defects have not been systematically studied.
To identify the mutation spectrum of CH-causing genes.
Fifty-five patients from 47 families were studied by next-generation exome sequencing.
Mutations were identified in 52.7% of patients (29 of 55) in the following 11 genes: TG, TPO, DUOX2, SLC26A4, SLC26A7, TSHB, TSHR, NKX2-1, PAX8, CDCA8, and HOXB3. Among 30 patients with thyroid dyshormonogenesis, biallelic TG mutations were found in 12 patients (40%), followed by biallelic mutations in TPO (6.7%), SLC26A7 (6.7%), and DUOX2 (3.3%). Monoallelic SLC26A4 mutations were found in two patients, one of them coexisting with two tandem biallelic deletions in SLC26A7. In 25 patients with thyroid dysgenesis, biallelic mutations in TSHR were found in six patients (24%). Biallelic mutations in TSHB, PAX 8, NKX2-1, or HOXB3 were found once in four different patients. A monoallelic CDCA8 mutation was found in one patient. Most mutations were novel, including three TG, two TSHR, and one each in DUOX2, TPO, SLC26A7, TSHB, NKX2-1, PAX8, CDCA8, and HOXB3. SLC26A7 and HOXB3 were novel genes associated with thyroid dyshormonogenesis and dysgenesis, respectively.
TG and TSHR mutations are the most common genetic defects in Saudi patients with CH. The prevalence of other disease-causing mutations is low, reflecting the consanguineous nature of the population. SLC26A7 mutations appear to be associated with thyroid dyshormonogenesis.
先天性甲状腺功能减退症(CH)是最常见的新生儿内分泌疾病,影响每 3000 至 4000 名新生儿中的 1 名。自 1988 年引入新生儿筛查计划以来,已发现 300 多例。潜在的遗传缺陷尚未得到系统研究。
确定导致 CH 的基因突变谱。
对 47 个家系的 55 名患者进行下一代外显子组测序。
在 55 名患者(29 名,52.7%)中发现了以下 11 个基因的突变:TG、TPO、DUOX2、SLC26A4、SLC26A7、TSHB、TSHR、NKX2-1、PAX8、CDCA8 和 HOXB3。在 30 名甲状腺激素生成障碍患者中,12 名患者(40%)存在 TG 双等位基因突变,其次是 TPO(6.7%)、SLC26A7(6.7%)和 DUOX2(3.3%)的双等位基因突变。两名患者存在 SLC26A4 单等位基因突变,其中一名患者还存在 SLC26A7 两个串联双等位基因缺失。在 25 名甲状腺发育不良患者中,6 名患者(24%)存在 TSHR 双等位基因突变。另外 4 名不同患者中各发现一次 TSHB、PAX8、NKX2-1 或 HOXB3 的双等位基因突变。一名患者存在 CDCA8 单等位基因突变。大多数突变是新发现的,包括 3 个 TG、2 个 TSHR,以及 DUOX2、TPO、SLC26A7、TSHB、NKX2-1、PAX8、CDCA8 和 HOXB3 各 1 个。SLC26A7 和 HOXB3 分别是与甲状腺激素生成障碍和发育不良相关的新基因。
在沙特阿拉伯 CH 患者中,TG 和 TSHR 突变是最常见的遗传缺陷。其他致病突变的患病率较低,反映了人群的近亲结婚性质。SLC26A7 突变似乎与甲状腺激素生成障碍有关。